Magzter GOLDで無制限に

Magzter GOLDで無制限に

10,000以上の雑誌、新聞、プレミアム記事に無制限にアクセスできます。

$149.99
 
$74.99/年

試す - 無料

Director's act

THE WEEK India

|

March 31, 2024

Established Malayalam filmmakers and writers are taking up lead roles

- NIRMAL JOVIAL

Director's act

In Indian film industries, there is a prevailing belief that pan-India success is reserved for mega-budget films featuring larger-than-life characters capable of executing extreme action. The monumental, nationwide success of Tollywood’s epic film Baahubali: The Beginning (2015) laid the foundation for this notion. Post-pandemic, Malayalam cinema gained significant traction and appreciation across India, thanks to its content-driven offerings on OTT platforms. However, attempts by the industry to crack the pan-India success code by emulating the style-over-substance formula, successfully executed in Tamil or Telugu cinema, resulted in dismal failures. But February 2024 brought with it an epiphany of sorts for Malayalam cinema—it realised that it could maintain its focus on content-driven filmmaking and still achieve pan-Indian appeal.

Dubbed “super February”, the last month saw a diverse range of Malayalam films sending cash registers ringing countrywide. Director Chidambaram’s Manjummel Boys was the biggest blockbuster. Based on a real-life story from 2006, it shows 11 young men from Manjummel near Kochi on a fateful mission to save a friend who fell into a crevasse during their trip to Guna Caves in Kodaikanal. With a budget nearing ₹20 crore, this survival thriller has grossed more than ₹200 crore and continues its successful theatrical run. Gireesh A.D.’s Premalu (₹10 crore), a romantic comedy, has crossed the ₹100-crore mark, while Rahul Sadasivan’s horror film Bramayugam (₹27.73 crore) has raked in over ₹85 crore.

THE WEEK India からのその他のストーリー

THE WEEK India

THE WEEK India

Fire, smoke and soaring worries

The PSLV C-62 fiasco is a stress test of ISRO's technical systems, organisational processes and market credibility

time to read

7 mins

January 25, 2026

THE WEEK India

THE WEEK India

The dinosaur and the dictator

Dictators have a few things in common with T. rex, the king of dinosaurs. Both dominate their sphere of influence through brute force.

time to read

2 mins

January 25, 2026

THE WEEK India

We are developing master plans for tourism destinations

Across the world, the tourism development is more about providing seamless connection and basic infra like transportation, lodging and boarding.

time to read

2 mins

January 25, 2026

THE WEEK India

THE WEEK India

A TIGHTROPE WALK

As small-caps are yet to find valuation comfort, 2026 would be a challenging year for them

time to read

4 mins

January 25, 2026

THE WEEK India

THE WEEK India

ON THIN ICE

With the intensification of great-power rivalries in the region, Greenland's strategic and resource potential has become salient

time to read

5 mins

January 25, 2026

THE WEEK India

THE WEEK India

Elgin, Ephesus and Erdogan

Lord Elgin was wrong. Not the eighth earl whom we know as a viceroy of India, but his more famous father, the seventh who had carted away the Parthenon Marbles from Athens during 1802-1812. Elgin feared the Ottoman Turks, who had occupied Greece, might vandalise them.

time to read

2 mins

January 25, 2026

THE WEEK India

THE WEEK India

Art at the heart

The sixth edition of the Kochi-Muziris Biennale reclaims its legacy

time to read

6 mins

January 25, 2026

THE WEEK India

THE WEEK India

BENIGN PROSTATIC HYPERPLASIA (BPH): Understanding Symptoms, Diagnosis & Modern Treatment Options

Benign Prostatic Hyperplasia (BPH) is a very common medical condition affecting aging men, particularly those above 50 years.

time to read

2 mins

January 25, 2026

THE WEEK India

THE WEEK India

ERA OF THE NEW NORMAL

The confrontations with China and Pakistan have added another dimension to the ever-evolving nature of the Indian military

time to read

5 mins

January 25, 2026

THE WEEK India

THE WEEK India

Affordable CAR-T Therapy Brings New Hope for Blood Cancer Patients in India

For thousands of Indians battling blood cancers, a once-unimaginable dream is fast becoming reality. Cutting-edge CART cell therapy a breakthrough treatment that uses a patient's own immune system to fight cancer is now available in India at a fraction of global costs, offering renewed hope to patients with advanced disease.

time to read

1 mins

January 25, 2026

Listen

Translate

Share

-
+

Change font size